LICHEN SIMPLEX CHRONICUS
Clinical trials for LICHEN SIMPLEX CHRONICUS explained in plain language.
Never miss a new study
Get alerted when new LICHEN SIMPLEX CHRONICUS trials appear
Sign up with your email to follow new studies for LICHEN SIMPLEX CHRONICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for relentless itch: phase 3 drug trial targets lichen simplex chronicus
Symptom relief OngoingThis study tests if dupilumab injections can reduce severe itching in adults with lichen simplex chronicus, a condition causing thick, itchy skin patches. About 142 participants will receive either dupilumab or a placebo for 24 weeks. The main goal is to see if more people get me…
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 17, 2026 02:58 UTC
-
New hope for chronic itch sufferers: drug targets scratching cycle
Symptom relief OngoingThis study tests if dupilumab, given as injections, can reduce severe itching in adults with lichen simplex chronicus, a skin condition causing intense scratching. About 138 participants will receive either dupilumab or a placebo for 24 weeks, and researchers will measure itch im…
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 07, 2026 18:47 UTC